Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.23.1
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of warrant and stock option grants with time-based vesting
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of shares subject to warrants     Weighted-
average exercise price per share		     Number of shares subject to options     Weighted-
average exercise price per share		     Number of shares subject to restricted stock units  
Balance at December 31, 2021     1,043,525     $ 2.57       118,388     $ 3.25       2,160,757  
Granted     524,195       0.65      
-
      
-
       465,314  
Exercised    
-
      
-
      
-
      
-
       (216,312 )
Cancelled/Expired    
-
      
-
      
-
      
-
      
-
  
Balance at December 31, 2022     1,567,720     $ 1.35       118,388     $ 3.25       2,409,759  
Exercisable at December 31, 2022     1,567,720     $ 1.35       118,388     $ 3.25       2,267,175  

 
Schedule of company’s outstanding warrants and options
Warrants Outstanding     Warrants Exercisable  
Exercise Price Range     Number Outstanding     Weighted Average Remaining Contractual Life
(in years)		     Weighted Average Exercise Price     Number Exercisable     Weighted Average Exercise Price     Intrinsic Value  
$ 0.65 - $20.90       1,567,720       2.56     $ 1.35       1,567,720     $ 1.35       -  

 

Options Outstanding     Options Exercisable  
Exercise Price Range     Number Outstanding     Weighted Average Remaining Contractual Life
(in years)		     Weighted Average Exercise Price     Number Exercisable     Weighted Average Exercise Price     Intrinsic Value  
$ 2.64 - $6.84       118,388       1.69     $ 3.25       118,388     $ 3.25      
-
  

 
Schedule of stock-based compensation expense
    For the years ended  
    December 31,  
    2022     2021  
Stock-based compensation expense   $ 1,141,932     $ 2,687,901  

 
Schedule of stock-based compensation expense categorized by the equity components
    For the years ended  
    December 31,  
    2022     2021  
Common stock   $ 1,141,932     $ 2,687,901  
Total   $ 1,141,932     $ 2,687,901